GlaxoSmithKline Pharmaceuticals Limited (GLAXO) — Net Asset Momentum
GlaxoSmithKline Pharmaceuticals Limited (GLAXO) recorded a net asset momentum of 9.8% as of March 2025, with net assets of Rs19.51 Billion INR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See defensive interval ratio of GlaxoSmithKline Pharmaceuticals Limited to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
GlaxoSmithKline Pharmaceuticals Limited Net Asset Momentum (2005–2025)
This chart tracks GlaxoSmithKline Pharmaceuticals Limited's year-over-year net asset growth across 21 annual reporting periods from 2005 to 2025. The most recent momentum reading is +9.8%, with net assets of Rs19.51 Billion INR as of March 2025. Read GLAXO total liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for GlaxoSmithKline Pharmaceuticals Limited (2005–2025)
The table below shows the complete annual net asset history for GlaxoSmithKline Pharmaceuticals Limited from 2005 to 2025, covering 21 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see GLAXO market cap overview.
| Year | Net Assets (INR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | Rs19.51 Billion | Rs41.08 Billion | Rs21.57 Billion | ▲ +9.8% |
| 2024 | Rs17.78 Billion | Rs35.57 Billion | Rs17.79 Billion | ▲ +2.1% |
| 2023 | Rs17.41 Billion | Rs33.27 Billion | Rs15.85 Billion | ▼ -34.6% |
| 2022 | Rs26.63 Billion | Rs46.33 Billion | Rs19.70 Billion | ▲ +77.6% |
| 2021 | Rs14.99 Billion | Rs31.13 Billion | Rs16.14 Billion | ▼ -17.7% |
| 2020 | Rs18.21 Billion | Rs31.36 Billion | Rs13.15 Billion | ▼ -14.9% |
| 2019 | Rs21.40 Billion | Rs39.11 Billion | Rs17.71 Billion | ▲ +4.0% |
| 2018 | Rs20.57 Billion | Rs39.47 Billion | Rs18.90 Billion | ▲ +2.5% |
| 2017 | Rs20.07 Billion | Rs30.04 Billion | Rs9.97 Billion | ▲ +18.3% |
| 2016 | Rs16.96 Billion | Rs30.46 Billion | Rs13.50 Billion | ▼ -30.6% |
| 2015 | Rs24.44 Billion | Rs32.24 Billion | Rs7.80 Billion | ▲ +22.8% |
| 2014 | Rs19.90 Billion | Rs31.30 Billion | Rs11.40 Billion | ▼ -0.9% |
| 2013 | Rs20.07 Billion | Rs30.88 Billion | Rs10.82 Billion | ▲ +3.7% |
| 2012 | Rs19.36 Billion | Rs30.66 Billion | Rs11.30 Billion | ▼ -0.8% |
| 2011 | Rs19.52 Billion | Rs28.10 Billion | Rs8.59 Billion | ▲ +9.3% |
| 2010 | Rs17.86 Billion | Rs24.98 Billion | Rs7.12 Billion | ▲ +13.4% |
| 2009 | Rs15.76 Billion | Rs23.21 Billion | Rs7.45 Billion | ▲ +14.1% |
| 2008 | Rs13.81 Billion | Rs20.36 Billion | Rs6.55 Billion | ▲ +14.6% |
| 2007 | Rs12.05 Billion | Rs17.89 Billion | Rs5.84 Billion | ▲ +26.4% |
| 2006 | Rs9.53 Billion | Rs15.16 Billion | Rs5.63 Billion | ▲ +3.2% |
| 2005 | Rs9.24 Billion | Rs14.14 Billion | Rs4.90 Billion | — |